Skip to main content

Main menu

  • About
    • Our Mission
    • Donors
    • Board of Directors
    • Advisory Boards
    • Staff
    • Careers
    • FAQ
    • Annual Report
    • Louder Than TB
  • Why New TB Drugs?
    • Global Pandemic
    • Inadequate Treatment
    • Antimicrobial Resistance
    • Maternal and Child Health
    • Cycle of Poverty
  • R&D
    • Scientific Vision
    • Pipeline
    • Discovery
    • Developing New Regimens
    • Engaging Communities
  • Access
    • Our Commitment
    • Understanding the TB Market
    • Child-friendly medicines
    • Pretomanid and BPaL
  • News
    • Latest News
    • Publications
    • Voices of TB
    • Research Papers
    • 20 Years of Impact
  • Donate

Search form

Voices of TB

Videos from the Global Health Community

Featured Videos

Kenya Launches Child-Friendly TB Medicine

New Childhood TB Medicines Will Help Save Lives

Pediatric TB

Karl Hofmann: Better medicines for children with TB

Kenya Launches Child-Friendly TB Medicine

Thought Leader Series: Progress on Global Scale-up of Childhood TB Medicines

Overcoming TB in Children within our Communities

When my daughter learned she had TB

Addressing Childhood Tuberculosis: Opportunities for Maternal and Child Survival Platforms

New Childhood TB Medicines Will Help Save Lives

Childhood TB can be solved - if we choose to act

Saving Children's Lives

Emma Thompson and her son, Tindy

Thembi Jakiwe: Strength of a Woman

Thought Leader Series: New TB Drugs for Children: Planning for uptake, maximizing access

  • Show more videos

Filter by Subject

Community Engagement (16)
CPTR (5)
Drug-resistance (24)
Market Access (6)
Patient Stories (22)
Pediatric TB (21)
Resource Mobilization (8)
TB-HIV (6)
TB Research (23)
TB Awareness (29)
TB Alliance (26)
TB Advocacy (25)
Join our mailing list and receive the latest news from TB Alliance.
Interests

Our Mission

TB Alliance is a not-for-profit organization dedicated to the discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs that are available to those who need them.

Navigate

  • About
  • Why New TB Drugs?
  • R&D
  • Access
  • News
  • Donate

News Headlines

A Persistent Shortfall in TB Research and Development Funding
Astellas and TB Alliance Enter into a New Collaborative Research Agreement to Identify Lead Compounds for the Treatment of Tuberculosis
STAND Clinical Trial Results Published

Contact Us

Press Inquiries

Thomas Lynch
p | +1 646 616 8639
e | thomas.lynch@tballiance.org

Jobs

View job openings at the TB Alliance

Report a Concern

New York:

40 Wall Street, 24th floor, New York, NY 10005 • +1 212 227 7540

Pretoria:

Boardwalk Office Park, Block 1/Suite 5, 107 Haymeadow Street, Faerie Glen, Pretoria 0043, South Africa • +27 12 991 6328
© 2021 The TB Alliance. All Rights Reserved. Site by Darby Communications Report a Concern